Clinical Trial Update: A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction [Phase 3]

View source ↗

Summary

A Phase 3 unicentric, randomized, placebo-controlled, double-blind trial is evaluating the efficacy and safety of topical alendronic acid for alveolar bone remo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss

Drugs mentioned

• Topical Alendronic Acid (alendronic acid)

Snippet

Sponsor: Xeolas Pharmaceuticals Limited | Conditions: Bone Loss, Alveolar | Phase 3 | Status: ACTIVE_NOT_RECRUITING